ExploreStudyPMC5986588
Study

PMC5986588

18 findings 1 paper 15 related entities View in graph →

Related entities

interventions
conditions
outcomes
populations

Findings (50)

None
null

Chemotherapy treatment intensity (HDMTX exposure, intrathecal therapy doses, and cumulative dexamethasone dose) was not associated with any child self-reported or parent-reported behavioral symptoms o

Effect: null; RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all p-values > 0.05 after FDR correction across all treatment-outcome combinations

Size: RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all
None
null

Chemotherapy treatment intensity (HDMTX exposure, intrathecal therapy doses, and cumulative dexamethasone dose) was not associated with any child self-reported or parent-reported behavioral symptoms o

Effect: null; RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all p-values > 0.05 after FDR correction across all treatment-outcome combinations

Size: RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all
None
null

Chemotherapy treatment intensity (HDMTX exposure, intrathecal therapy doses, and cumulative dexamethasone dose) was not associated with any child self-reported or parent-reported behavioral symptoms o

Effect: null; RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all p-values > 0.05 after FDR correction across all treatment-outcome combinations

Size: RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all
None
null

Chemotherapy treatment intensity (HDMTX exposure, intrathecal therapy doses, and cumulative dexamethasone dose) was not associated with any child self-reported or parent-reported behavioral symptoms o

Effect: null; RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all p-values > 0.05 after FDR correction across all treatment-outcome combinations

Size: RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all
None
null

Chemotherapy treatment intensity (HDMTX exposure, intrathecal therapy doses, and cumulative dexamethasone dose) was not associated with any child self-reported or parent-reported behavioral symptoms o

Effect: null; RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all p-values > 0.05 after FDR correction across all treatment-outcome combinations

Size: RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all
None
null

Chemotherapy treatment intensity (HDMTX exposure, intrathecal therapy doses, and cumulative dexamethasone dose) was not associated with any child self-reported or parent-reported behavioral symptoms o

Effect: null; RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all p-values > 0.05 after FDR correction across all treatment-outcome combinations

Size: RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all
None
null

Chemotherapy treatment intensity (HDMTX exposure, intrathecal therapy doses, and cumulative dexamethasone dose) was not associated with any child self-reported or parent-reported behavioral symptoms o

Effect: null; RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all p-values > 0.05 after FDR correction across all treatment-outcome combinations

Size: RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all
None
null

Chemotherapy treatment intensity (HDMTX exposure, intrathecal therapy doses, and cumulative dexamethasone dose) was not associated with any child self-reported or parent-reported behavioral symptoms o

Effect: null; RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all p-values > 0.05 after FDR correction across all treatment-outcome combinations

Size: RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all
None
null

Chemotherapy treatment intensity (HDMTX exposure, intrathecal therapy doses, and cumulative dexamethasone dose) was not associated with any child self-reported or parent-reported behavioral symptoms o

Effect: null; RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all p-values > 0.05 after FDR correction across all treatment-outcome combinations

Size: RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all
None
null

Chemotherapy treatment intensity (HDMTX exposure, intrathecal therapy doses, and cumulative dexamethasone dose) was not associated with any child self-reported or parent-reported behavioral symptoms o

Effect: null; RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all p-values > 0.05 after FDR correction across all treatment-outcome combinations

Size: RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all
None
null

Chemotherapy treatment intensity (HDMTX exposure, intrathecal therapy doses, and cumulative dexamethasone dose) was not associated with any child self-reported or parent-reported behavioral symptoms o

Effect: null; RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all p-values > 0.05 after FDR correction across all treatment-outcome combinations

Size: RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all
None
null

Chemotherapy treatment intensity (HDMTX exposure, intrathecal therapy doses, and cumulative dexamethasone dose) was not associated with any child self-reported or parent-reported behavioral symptoms o

Effect: null; RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all p-values > 0.05 after FDR correction across all treatment-outcome combinations

Size: RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all
None
null

Chemotherapy treatment intensity (HDMTX exposure, intrathecal therapy doses, and cumulative dexamethasone dose) was not associated with any child self-reported or parent-reported behavioral symptoms o

Effect: null; RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all p-values > 0.05 after FDR correction across all treatment-outcome combinations

Size: RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all
None
null

Chemotherapy treatment intensity (HDMTX exposure, intrathecal therapy doses, and cumulative dexamethasone dose) was not associated with any child self-reported or parent-reported behavioral symptoms o

Effect: null; RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all p-values > 0.05 after FDR correction across all treatment-outcome combinations

Size: RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all
None
null

Chemotherapy treatment intensity (HDMTX exposure, intrathecal therapy doses, and cumulative dexamethasone dose) was not associated with any child self-reported or parent-reported behavioral symptoms o

Effect: null; RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all p-values > 0.05 after FDR correction across all treatment-outcome combinations

Size: RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all
None
null

Chemotherapy treatment intensity (HDMTX exposure, intrathecal therapy doses, and cumulative dexamethasone dose) was not associated with any child self-reported or parent-reported behavioral symptoms o

Effect: null; RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all p-values > 0.05 after FDR correction across all treatment-outcome combinations

Size: RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all
None
null

Chemotherapy treatment intensity (HDMTX exposure, intrathecal therapy doses, and cumulative dexamethasone dose) was not associated with any child self-reported or parent-reported behavioral symptoms o

Effect: null; RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all p-values > 0.05 after FDR correction across all treatment-outcome combinations

Size: RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all
None
null

Chemotherapy treatment intensity (HDMTX exposure, intrathecal therapy doses, and cumulative dexamethasone dose) was not associated with any child self-reported or parent-reported behavioral symptoms o

Effect: null; RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all p-values > 0.05 after FDR correction across all treatment-outcome combinations

Size: RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all
None
null

Chemotherapy treatment intensity (HDMTX exposure, intrathecal therapy doses, and cumulative dexamethasone dose) was not associated with any child self-reported or parent-reported behavioral symptoms o

Effect: null; RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all p-values > 0.05 after FDR correction across all treatment-outcome combinations

Size: RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all
None
null

Chemotherapy treatment intensity (HDMTX exposure, intrathecal therapy doses, and cumulative dexamethasone dose) was not associated with any child self-reported or parent-reported behavioral symptoms o

Effect: null; RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all p-values > 0.05 after FDR correction across all treatment-outcome combinations

Size: RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all
None
null

Chemotherapy treatment intensity (HDMTX exposure, intrathecal therapy doses, and cumulative dexamethasone dose) was not associated with any child self-reported or parent-reported behavioral symptoms o

Effect: null; RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all p-values > 0.05 after FDR correction across all treatment-outcome combinations

Size: RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all
None
null

Chemotherapy treatment intensity (HDMTX exposure, intrathecal therapy doses, and cumulative dexamethasone dose) was not associated with any child self-reported or parent-reported behavioral symptoms o

Effect: null; RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all p-values > 0.05 after FDR correction across all treatment-outcome combinations

Size: RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all
None
null

Chemotherapy treatment intensity (HDMTX exposure, intrathecal therapy doses, and cumulative dexamethasone dose) was not associated with any child self-reported or parent-reported behavioral symptoms o

Effect: null; RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all p-values > 0.05 after FDR correction across all treatment-outcome combinations

Size: RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all
None
null

Chemotherapy treatment intensity (HDMTX exposure, intrathecal therapy doses, and cumulative dexamethasone dose) was not associated with any child self-reported or parent-reported behavioral symptoms o

Effect: null; RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all p-values > 0.05 after FDR correction across all treatment-outcome combinations

Size: RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all
None
null

Chemotherapy treatment intensity (HDMTX exposure, intrathecal therapy doses, and cumulative dexamethasone dose) was not associated with any child self-reported or parent-reported behavioral symptoms o

Effect: null; RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all p-values > 0.05 after FDR correction across all treatment-outcome combinations

Size: RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all
None
null

Chemotherapy treatment intensity (HDMTX exposure, intrathecal therapy doses, and cumulative dexamethasone dose) was not associated with any child self-reported or parent-reported behavioral symptoms o

Effect: null; RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all p-values > 0.05 after FDR correction across all treatment-outcome combinations

Size: RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all
None
null

Chemotherapy treatment intensity (HDMTX exposure, intrathecal therapy doses, and cumulative dexamethasone dose) was not associated with any child self-reported or parent-reported behavioral symptoms o

Effect: null; RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all p-values > 0.05 after FDR correction across all treatment-outcome combinations

Size: RR 0.98 (95% CI 0.96-1.01) for HDMTX AUC on inattention; all
None
decline

Parent emotional distress and PTSS were significantly associated with parent-reported child anxiety disorders (GAD, OCD) and atypicality, but NOT with the survivor's own self-reported anxiety symptoms

Effect: decline; Parent self-reported anxiety, depression and PTSS showed significantly higher risk for parent report of survivor anxiety, atypicality, Genera

Size: Parent self-reported anxiety, depression and PTSS showed sig
None
decline

Parent emotional distress and PTSS were significantly associated with parent-reported child anxiety disorders (GAD, OCD) and atypicality, but NOT with the survivor's own self-reported anxiety symptoms

Effect: decline; Parent self-reported anxiety, depression and PTSS showed significantly higher risk for parent report of survivor anxiety, atypicality, Genera

Size: Parent self-reported anxiety, depression and PTSS showed sig
None
decline

Parent emotional distress and PTSS were significantly associated with parent-reported child anxiety disorders (GAD, OCD) and atypicality, but NOT with the survivor's own self-reported anxiety symptoms

Effect: decline; Parent self-reported anxiety, depression and PTSS showed significantly higher risk for parent report of survivor anxiety, atypicality, Genera

Size: Parent self-reported anxiety, depression and PTSS showed sig
None
decline

Parent emotional distress and PTSS were significantly associated with parent-reported child anxiety disorders (GAD, OCD) and atypicality, but NOT with the survivor's own self-reported anxiety symptoms

Effect: decline; Parent self-reported anxiety, depression and PTSS showed significantly higher risk for parent report of survivor anxiety, atypicality, Genera

Size: Parent self-reported anxiety, depression and PTSS showed sig
None
decline

Parent emotional distress and PTSS were significantly associated with parent-reported child anxiety disorders (GAD, OCD) and atypicality, but NOT with the survivor's own self-reported anxiety symptoms

Effect: decline; Parent self-reported anxiety, depression and PTSS showed significantly higher risk for parent report of survivor anxiety, atypicality, Genera

Size: Parent self-reported anxiety, depression and PTSS showed sig
None
decline

Parent emotional distress and PTSS were significantly associated with parent-reported child anxiety disorders (GAD, OCD) and atypicality, but NOT with the survivor's own self-reported anxiety symptoms

Effect: decline; Parent self-reported anxiety, depression and PTSS showed significantly higher risk for parent report of survivor anxiety, atypicality, Genera

Size: Parent self-reported anxiety, depression and PTSS showed sig
None
decline

Parent emotional distress and PTSS were significantly associated with parent-reported child anxiety disorders (GAD, OCD) and atypicality, but NOT with the survivor's own self-reported anxiety symptoms

Effect: decline; Parent self-reported anxiety, depression and PTSS showed significantly higher risk for parent report of survivor anxiety, atypicality, Genera

Size: Parent self-reported anxiety, depression and PTSS showed sig
None
decline

Parent emotional distress and PTSS were significantly associated with parent-reported child anxiety disorders (GAD, OCD) and atypicality, but NOT with the survivor's own self-reported anxiety symptoms

Effect: decline; Parent self-reported anxiety, depression and PTSS showed significantly higher risk for parent report of survivor anxiety, atypicality, Genera

Size: Parent self-reported anxiety, depression and PTSS showed sig
None
decline

Parent emotional distress and PTSS were significantly associated with parent-reported child anxiety disorders (GAD, OCD) and atypicality, but NOT with the survivor's own self-reported anxiety symptoms

Effect: decline; Parent self-reported anxiety, depression and PTSS showed significantly higher risk for parent report of survivor anxiety, atypicality, Genera

Size: Parent self-reported anxiety, depression and PTSS showed sig
None
decline

Parent emotional distress and PTSS were significantly associated with parent-reported child anxiety disorders (GAD, OCD) and atypicality, but NOT with the survivor's own self-reported anxiety symptoms

Effect: decline; Parent self-reported anxiety, depression and PTSS showed significantly higher risk for parent report of survivor anxiety, atypicality, Genera

Size: Parent self-reported anxiety, depression and PTSS showed sig
None
decline

Parent emotional distress and PTSS were significantly associated with parent-reported child anxiety disorders (GAD, OCD) and atypicality, but NOT with the survivor's own self-reported anxiety symptoms

Effect: decline; Parent self-reported anxiety, depression and PTSS showed significantly higher risk for parent report of survivor anxiety, atypicality, Genera

Size: Parent self-reported anxiety, depression and PTSS showed sig
None
decline

Parent emotional distress and PTSS were significantly associated with parent-reported child anxiety disorders (GAD, OCD) and atypicality, but NOT with the survivor's own self-reported anxiety symptoms

Effect: decline; Parent self-reported anxiety, depression and PTSS showed significantly higher risk for parent report of survivor anxiety, atypicality, Genera

Size: Parent self-reported anxiety, depression and PTSS showed sig
None
decline

Parent emotional distress and PTSS were significantly associated with parent-reported child anxiety disorders (GAD, OCD) and atypicality, but NOT with the survivor's own self-reported anxiety symptoms

Effect: decline; Parent self-reported anxiety, depression and PTSS showed significantly higher risk for parent report of survivor anxiety, atypicality, Genera

Size: Parent self-reported anxiety, depression and PTSS showed sig
None
decline

Parent emotional distress and PTSS were significantly associated with parent-reported child anxiety disorders (GAD, OCD) and atypicality, but NOT with the survivor's own self-reported anxiety symptoms

Effect: decline; Parent self-reported anxiety, depression and PTSS showed significantly higher risk for parent report of survivor anxiety, atypicality, Genera

Size: Parent self-reported anxiety, depression and PTSS showed sig
None
decline

Parent emotional distress and PTSS were significantly associated with parent-reported child anxiety disorders (GAD, OCD) and atypicality, but NOT with the survivor's own self-reported anxiety symptoms

Effect: decline; Parent self-reported anxiety, depression and PTSS showed significantly higher risk for parent report of survivor anxiety, atypicality, Genera

Size: Parent self-reported anxiety, depression and PTSS showed sig
None
decline

Parent emotional distress and PTSS were significantly associated with parent-reported child anxiety disorders (GAD, OCD) and atypicality, but NOT with the survivor's own self-reported anxiety symptoms

Effect: decline; Parent self-reported anxiety, depression and PTSS showed significantly higher risk for parent report of survivor anxiety, atypicality, Genera

Size: Parent self-reported anxiety, depression and PTSS showed sig
None
decline

Parent emotional distress and PTSS were significantly associated with parent-reported child anxiety disorders (GAD, OCD) and atypicality, but NOT with the survivor's own self-reported anxiety symptoms

Effect: decline; Parent self-reported anxiety, depression and PTSS showed significantly higher risk for parent report of survivor anxiety, atypicality, Genera

Size: Parent self-reported anxiety, depression and PTSS showed sig
None
decline

Parent emotional distress and PTSS were significantly associated with parent-reported child anxiety disorders (GAD, OCD) and atypicality, but NOT with the survivor's own self-reported anxiety symptoms

Effect: decline; Parent self-reported anxiety, depression and PTSS showed significantly higher risk for parent report of survivor anxiety, atypicality, Genera

Size: Parent self-reported anxiety, depression and PTSS showed sig
None
decline

Parent emotional distress and PTSS were significantly associated with parent-reported child anxiety disorders (GAD, OCD) and atypicality, but NOT with the survivor's own self-reported anxiety symptoms

Effect: decline; Parent self-reported anxiety, depression and PTSS showed significantly higher risk for parent report of survivor anxiety, atypicality, Genera

Size: Parent self-reported anxiety, depression and PTSS showed sig
None
decline

Parent emotional distress and PTSS were significantly associated with parent-reported child anxiety disorders (GAD, OCD) and atypicality, but NOT with the survivor's own self-reported anxiety symptoms

Effect: decline; Parent self-reported anxiety, depression and PTSS showed significantly higher risk for parent report of survivor anxiety, atypicality, Genera

Size: Parent self-reported anxiety, depression and PTSS showed sig
None
decline

Parent emotional distress and PTSS were significantly associated with parent-reported child anxiety disorders (GAD, OCD) and atypicality, but NOT with the survivor's own self-reported anxiety symptoms

Effect: decline; Parent self-reported anxiety, depression and PTSS showed significantly higher risk for parent report of survivor anxiety, atypicality, Genera

Size: Parent self-reported anxiety, depression and PTSS showed sig
None
decline

Parent emotional distress and PTSS were significantly associated with parent-reported child anxiety disorders (GAD, OCD) and atypicality, but NOT with the survivor's own self-reported anxiety symptoms

Effect: decline; Parent self-reported anxiety, depression and PTSS showed significantly higher risk for parent report of survivor anxiety, atypicality, Genera

Size: Parent self-reported anxiety, depression and PTSS showed sig
None
decline

Parent emotional distress and PTSS were significantly associated with parent-reported child anxiety disorders (GAD, OCD) and atypicality, but NOT with the survivor's own self-reported anxiety symptoms

Effect: decline; Parent self-reported anxiety, depression and PTSS showed significantly higher risk for parent report of survivor anxiety, atypicality, Genera

Size: Parent self-reported anxiety, depression and PTSS showed sig

Papers (1)